Document Details

MGEN $0.67 $ - 0.10 (13.41%)
Document Details

Filing Type

8-K (SEC's EDGAR System)

Company Miragen Therapeutics (Boulder, CO)
Event Date 12/11/2019
Filing Date 12/11/2019

Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement; Costs Associated with Exit or Disposal Activities; Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Regulation FD Disclosure; Other Events; and Financial Statements and Exhibits.

File Section(s)

  1. 8-K
  2. EXHIBIT 4.1
  3. EXHIBIT 5.1
  4. EXHIBIT 10.1
  5. EXHIBIT 99.1

Note: This document was filed with the SEC in HTML format, as allowed by the recent EDGAR system modernization. S&P cannot take responsibility for its appearance, layout, or legibility.